News
AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...
Monday said that the European Patent Office (EPO) has issued a notice of allowance for a composition of matter patent covering its drug candidate LP-284.
5d
Zacks Investment Research on MSNMDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing RightsMadrigal Pharmaceuticals MDGL shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark ...
Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...
World IP Review is set to host the highly anticipated AI and IP USA 2025, a one-day event on October 9, 2025 in New York. The ...
Opinion: Knobbe Marten's Ted Cannon analyzes the sharp rise in denials of patent validity challenges at the Patent Trial and Appeal Board and explains why filing a petition promptly can help a ...
NEW YORK-- (BUSINESS WIRE)-- Patlytics, the AI-powered patent workflow platform, today announced the appointment of Michelle K. Lee as Senior Strategic Advisor. A pioneering and respected leader ...
You successfully represented Regeneron Pharmaceuticals Inc. in Regeneron Pharmaceuticals Inc. v. Mylan Pharmaceuticals, Inc., in which the US District Court for the Northern District of West Virginia ...
Samsung secures interim patent licence in UK court ruling against ZTE, a key step in a multi-country FRAND dispute over mobile technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results